Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

TANDLÆGEKLINIKKEN VESTERBROGADE 11A ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.5%   Bankruptcy risk   1.6% 4.1% 1.6% 1.6% 1.2% 4.8% 19.7% 18.1%   Credit score (0-100)   77 51 75 75 80 45 5 8   Credit rating   A BBB A A A BBB B B   Credit limit (kDKK)   7.6 0.0 7.2 7.7 112.7 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   3,744 3,207 4,573 3,527 3,816 4,118 0.0 0.0   EBITDA   711 -117 1,772 896 1,572 3,115 0.0 0.0   EBIT   445 -389 1,530 694 1,481 3,054 0.0 0.0   Pre-tax profit (PTP)   400.0 -415.0 1,509.0 668.0 1,408.0 3,018.4 0.0 0.0   Net earnings   460.0 -324.0 1,177.0 521.0 1,097.0 2,331.2 0.0 0.0   Pre-tax profit without non-rec. items   400 -415 1,509 668 1,408 3,018 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Tangible assets total   573 345 241 87.0 206 117 0.0 0.0   Shareholders equity total   1,446 1,016 2,193 1,714 2,311 2,643 118 118   Interest-bearing liabilities   593 482 0.0 608 1,135 0.0 0.0 0.0   Balance sheet total (assets)   3,007 2,528 2,851 3,231 4,147 3,563 118 118   Net Debt   -812 -433 -1,509 -1,764 -2,070 -458 -118 -118     See the entire balance sheet 1000.0 Volume  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   3,744 3,207 4,573 3,527 3,816 4,118 0.0 0.0   Gross profit growth   17.5% -14.3% 42.6% -22.9% 8.2% 7.9% -100.0% 0.0%   Employees   7 7 6 5 5 1 0 0   Employee growth %   16.7% 0.0% -14.3% -16.7% 0.0% -80.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,007 2,528 2,851 3,231 4,147 3,563 118 118   Balance sheet change%   13.6% -15.9% 12.8% 13.3% 28.4% -14.1% -96.7% 0.0%   Added value   711.0 -117.0 1,772.0 896.0 1,683.0 3,115.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -415 -275 -353 -390 1 -517 -117 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 -1.0 1.0 2.0 3.0 4.0 0.0 0.0   1000.0 Profitability  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   11.9% -12.1% 33.5% 19.7% 38.8% 74.2% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   15.7% -13.7% 57.1% 23.0% 40.2% 79.4% 0.0% 0.0%   ROI %   23.9% -21.4% 81.1% 29.4% 49.1% 97.9% 0.0% 0.0%   ROE %   37.8% -26.3% 73.4% 26.7% 54.5% 94.1% 0.0% 0.0%   1000.0 Solidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Equity ratio %   48.1% 40.2% 76.9% 53.0% 55.7% 74.2% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -114.2% 370.1% -85.2% -196.9% -131.7% -14.7% 0.0% 0.0%   Gearing %   41.0% 47.4% 0.0% 35.5% 49.1% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   6.9% 6.7% 10.8% 9.9% 8.5% 7.2% 0.0% 0.0%   1000.0 Liquidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Quick Ratio   1.3 1.0 3.5 1.8 2.1 3.8 0.0 0.0   Current Ratio   1.4 1.2 3.9 2.0 2.1 3.8 0.0 0.0   Cash and cash equivalent   1,405.0 915.0 1,509.0 2,372.0 3,205.0 458.2 0.0 0.0   1000.0 Capital use efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   663.0 234.0 1,615.0 1,366.0 1,871.0 2,550.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   102 -17 295 179 337 3,115 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   102 -17 295 179 314 3,115 0 0   EBIT / employee   64 -56 255 139 296 3,054 0 0   Net earnings / employee   66 -46 196 104 219 2,331 0 0